Breaking News Instant updates and real-time market news.

RHHBY

Roche

$0.00

(0.00%)

12:41
10/04/18
10/04
12:41
10/04/18
12:41

Roche's Genentech announces FDA approval of Hemlibra for Hemophilia A

Genentech, a member of the Roche Group, announced that the U.S. FDA has approved Hemlibra for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A without factor VIII inhibitors. Hemlibra is now the only prophylactic treatment for people with hemophilia A with and without factor VIII inhibitors that can be administered subcutaneously and at multiple dosing options. This approval is based on positive results from the Phase III HAVEN 3 and HAVEN 4 studies. Hemlibra prophylaxis led to statistically significant and clinically meaningful reductions in treated bleeds compared to no prophylaxis and across all other bleed-related endpoints in the HAVEN 3 study, and showed a clinically meaningful control of bleeding in the HAVEN 4 study. Hemlibra is now available to people in the U.S. who have hemophilia A without factor VIII inhibitors.

  • 04

    Oct

  • 16

    Oct

  • 19

    Oct

  • 24

    Dec

RHHBY Roche
$0.00

(0.00%)

09/17/18
OPCO
09/17/18
NO CHANGE
Target $400
OPCO
Outperform
Roche's AD updates provide favorable read-through for Biogen, says Oppenheimer
Oppenheimer analyst Jay Olson says he remain bullish on Biogen (BIIB), telling investors in a research note that he believes Roche's (RHHBY) Alzheimer's disease updates provide a favorable read-through for Biogen's own Alzheimer's disease portfolio. Among the takeaways from Roche's pipeline update are the importance of a reduction in amyloid, confidence in dose escalation, epidemiology estimate and reimbursement commentary. Olson, who has an Outperform rating and $400 price target on Biogen, says he believes shares are undervalued based on his view that the company's leadership position in neuroscience should deliver long-term growth.
09/21/18
PIPR
09/21/18
NO CHANGE
Target $400
PIPR
Overweight
Biogen upcoming BIIB098 data an overlooked catalyst, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond believes investor sentiment on Biogen (BIIB) overlooks the H2H tolerability data for BIIB098 versus Tecfidera coming in the first half of 2018 Though BIIB098 is largely discounted as an intellectual property play "or worse," the readout, if positive, may be an important catalyst ahead of FDA approval in Q4 of 2019, Raymond tells investors in a research note. He suspects that if BIIB098 shows meaningful tolerability improvement over Tecfidera, "docs will likely take notice." Further, Raymond's new neurologist survey indicates that while the launch trends of Roche's (RHHBY) multiple sclerosis drugOcrevus "appear to be improving," other share trends, including those for Tecfidera and Tysabri, "remain stable." The analyst keeps an Overweight rating on Biogen with a $400 price target.
10/03/18
PIPR
10/03/18
NO CHANGE
PIPR
Overweight
PTC, Roche data add uncertainty to Biogen drug outlook, says Piper Jaffray
The risdiplam spinal muscular atrophy data released this morning by PTC Therapeutic (PTCT) and Roche (RHHBY) stack up fairly well to Biogen's (BIIB) Spinraza clinical data, Piper Jaffray analyst Christopher Raymond tells investors in a research note. Even taking into account all of the usual caveats regarding cross-trial comparisons, risdiplam is shaping up well compared to Spinraza, the analyst contends. He sees the new data as adding uncertainty to the Spinraza trajectory. Nonetheless, Raymond keeps an Overweight rating on shares of Biogen. The analyst made no changes to his Biogen model, but he admits risdiplam, if the data holds up, may impact Spinraza's ultimate market potential. Biogen in midday trading is up 2% to $351.41.
10/03/18
BARD
10/03/18
NO CHANGE
Target $348
BARD
Neutral
Risdiplam data incrementally negative for Biogen, says Baird
Biogen analyst Brian Skorney views this morning's risdiplam data for use in treating spinal muscular atrophy patients as incrementally negative for Biogen (BIIB). The data from PTC Therapeutics (PTCT) and PTC Therapeutics (RHHBY) are compelling so far, and suggest that risdiplam could impact the market share of Biogen's Spinraza, if it comes to market, Skorney tells investors in a research note. He highlights risdiplam's convenience as an oral small molecule and says the Phase II data "continues to impress." The analyst keeps a Neutral rating on Biogen with a $348 price target. The stock in afternoon trading is up $6.90, or 2%, to $352.31.

TODAY'S FREE FLY STORIES

GOOG

Alphabet

$1,183.43

-14.58 (-1.22%)

, GOOGL

Alphabet Class A

$1,184.26

-15.68 (-1.31%)

19:02
08/20/19
08/20
19:02
08/20/19
19:02
Periodicals
YouTube intends to end targeted ads on videos aimed at children, Bloomberg says »

In an effort to satisfy…

GOOG

Alphabet

$1,183.43

-14.58 (-1.22%)

GOOGL

Alphabet Class A

$1,184.26

-15.68 (-1.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Oct

HMNY

Helios and Matheson

$0.00

(0.00%)

18:59
08/20/19
08/20
18:59
08/20/19
18:59
Periodicals
MoviePass exposed card data of thousands of customers, TechCrunch says »

MoviePass, which is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLM

PolyMet Mining

$0.34

-0.0125 (-3.60%)

18:49
08/20/19
08/20
18:49
08/20/19
18:49
Hot Stocks
PolyMet Mining reports court declined to hear petition for environmental review »

Poly Met Mining inc., a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$25.83

-0.27 (-1.03%)

18:24
08/20/19
08/20
18:24
08/20/19
18:24
Hot Stocks
American Airlines to pay $22.1M to settle DOJ false claims act allegations »

The U.S. Justice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

  • 23

    Sep

  • 14

    Nov

LZB

La-Z-Boy

$30.55

-1.325 (-4.16%)

, URBN

Urban Outfitters

$20.93

0.07 (0.34%)

18:17
08/20/19
08/20
18:17
08/20/19
18:17
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

LZB

La-Z-Boy

$30.55

-1.325 (-4.16%)

URBN

Urban Outfitters

$20.93

0.07 (0.34%)

LEDS

SemiLEDs

$2.22

-0.05 (-2.20%)

NRZ

New Residential

$14.14

-0.115 (-0.81%)

NDSN

Nordson

$135.43

-1.79 (-1.30%)

CREE

Cree

$58.19

-0.09 (-0.15%)

SCSC

Scansource

$31.23

-0.56 (-1.76%)

JKHY

Jack Henry

$140.79

-0.72 (-0.51%)

TSLA

Tesla

$225.70

-1.05 (-0.46%)

WMT

Walmart

$112.12

-1.64 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 20

    Aug

  • 20

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 27

    Aug

  • 09

    Sep

  • 11

    Sep

  • 12

    Sep

  • 15

    Sep

  • 19

    Sep

  • 23

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

LEDS

SemiLEDs

$2.22

-0.05 (-2.20%)

18:06
08/20/19
08/20
18:06
08/20/19
18:06
Hot Stocks
SemiLEDs receives offer from Chinese investor to acquire 680K shares »

On August 17, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$111.76

-0.72 (-0.64%)

18:01
08/20/19
08/20
18:01
08/20/19
18:01
Hot Stocks
Celanese announces ethyl acetate price increase in Europe »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$112.12

-1.64 (-1.44%)

17:50
08/20/19
08/20
17:50
08/20/19
17:50
Hot Stocks
Walmart's Furner sells nearly 8,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

SPY

SPDR S&P 500 ETF Trust

$290.03

-2.28 (-0.78%)

, SPX

S&P 500

$0.00

(0.00%)

17:49
08/20/19
08/20
17:49
08/20/19
17:49
Periodicals
Bond manager Gundlach says Fed 'has lost control,' Reuters reports »

According to often quoted…

SPY

SPDR S&P 500 ETF Trust

$290.03

-2.28 (-0.78%)

SPX

S&P 500

$0.00

(0.00%)

QQQ

Invesco QQQ Trust

$186.99

-1.3 (-0.69%)

DIA

Diamonds Fund ETF

$259.61

-1.71 (-0.65%)

SMH

Market Vectors Semiconductor

$113.43

-0.64 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URBN

Urban Outfitters

$20.93

0.07 (0.34%)

17:45
08/20/19
08/20
17:45
08/20/19
17:45
Earnings
Urban Outfitters CEO says Q2 was 'difficult quarter' for the company »

Urban Outfitter CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

  • 25

    Sep

17:45
08/20/19
08/20
17:45
08/20/19
17:45
General news
Breaking General news story  »

Federal Reserve Board of…

BA

Boeing

$331.94

-1.82 (-0.55%)

17:41
08/20/19
08/20
17:41
08/20/19
17:41
Hot Stocks
Boeing awarded $154.89M Army contract modification to procure Apache helicopters »

Boeing was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Sep

CGC

Canopy Growth

$27.21

0.48 (1.80%)

17:35
08/20/19
08/20
17:35
08/20/19
17:35
Hot Stocks
GTEC provides update on acquisition of Canopy Growth cultivation facility »

GTEC Holdings provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTRH

Waitr Holdings

$1.39

-0.045 (-3.15%)

17:34
08/20/19
08/20
17:34
08/20/19
17:34
Hot Stocks
Waitr Holdings jumps almost 9% after director Tilman Fertitta buys 1M shares »

Shares of Waitr Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 13

    Nov

XOM

Exxon Mobil

$69.03

-0.42 (-0.60%)

17:32
08/20/19
08/20
17:32
08/20/19
17:32
Initiation
Exxon Mobil initiated  »

Exxon Mobil initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$48.56

-0.38 (-0.78%)

17:30
08/20/19
08/20
17:30
08/20/19
17:30
Initiation
Total initiated  »

Total initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTRH

Waitr Holdings

$1.39

-0.045 (-3.15%)

17:28
08/20/19
08/20
17:28
08/20/19
17:28
Hot Stocks
Waitr Holdings director Tilman Fertitta buys 1M shares of company stock »

Waitr Holdings director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 13

    Nov

RDS.A

Royal Dutch Shell

$55.68

-0.405 (-0.72%)

17:27
08/20/19
08/20
17:27
08/20/19
17:27
Initiation
Royal Dutch Shell initiated  »

Royal Dutch Shell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEX

Emerald Expositions Events

$9.49

-0.035 (-0.37%)

17:23
08/20/19
08/20
17:23
08/20/19
17:23
Upgrade
Emerald Expositions Events rating change at Goldman Sachs »

Emerald Expositions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VG

Vonage

$13.34

-0.08 (-0.60%)

, FIVN

Five9

$62.48

0.23 (0.37%)

17:17
08/20/19
08/20
17:17
08/20/19
17:17
Conference/Events
Stephens Cloud Infrastructure Analyst to hold Analyst/Industry conference call »

Enterprise & Cloud…

VG

Vonage

$13.34

-0.08 (-0.60%)

FIVN

Five9

$62.48

0.23 (0.37%)

TWLO

Twilio

$126.89

1.27 (1.01%)

WORK

Slack Technologies

$30.50

-0.625 (-2.01%)

AMZN

Amazon.com

$1,802.08

-14.21 (-0.78%)

MSFT

Microsoft

$137.25

-1.18 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 04

    Sep

  • 04

    Sep

  • 05

    Sep

  • 10

    Sep

  • 27

    Oct

  • 13

    Nov

WMT

Walmart

$112.12

-1.64 (-1.44%)

, TSLA

Tesla

$225.70

-1.05 (-0.46%)

17:11
08/20/19
08/20
17:11
08/20/19
17:11
Periodicals
Walmart sues Tesla over solar panel fires, Bloomberg reports »

Walmart (WMT) is suing…

WMT

Walmart

$112.12

-1.64 (-1.44%)

TSLA

Tesla

$225.70

-1.05 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 15

    Sep

  • 23

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

GME

GameStop

$3.41

0.02 (0.59%)

17:07
08/20/19
08/20
17:07
08/20/19
17:07
Periodicals
GameStop cuts over 100 jobs, including nearly half of GI staff, Kotaku reports »

GameStop has laid off…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$8.54

-0.12 (-1.39%)

17:05
08/20/19
08/20
17:05
08/20/19
17:05
Syndicate
Breaking Syndicate news story on CEL-SCI »

CEL-SCI files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIQT

LiqTech

$6.76

0.32 (4.97%)

17:03
08/20/19
08/20
17:03
08/20/19
17:03
Conference/Events
LiqTech management to meet with Stephens »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 12

    Sep

HTBK

Heritage Commerce

$11.52

-0.08 (-0.69%)

16:54
08/20/19
08/20
16:54
08/20/19
16:54
Hot Stocks
Heritage Commerce receives regulatory approval for merger »

Heritage Commerce, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.